KinerjaPay Corp (fka KPAY)

[John23V]

Some Orgenesis articles. The joint venture hasn't been talked about enough. Orgenesis reports earnings on 10-14-19. Work plans from the 2 companies were to be submitted by July 6th to their formed steering committee, letting us know what each company's tasks would be. Sounds like Kinerjapay was going to be responsible from data from clinical trials. Looking forward to any information in the 10Q.

From 5-6-19 the JV filing:
https://ir.orgenesis.com/all-sec-filings/content/0001062993-19-002066/exhibit10-3.htm

From 8-12-19, 16 mil in cash, 1 mil from new POCare Platform
https://www.globenewswire.com/news-release/2019/08/12/1900441/0/en/Orgenesis-Second-Quarter-2019-Revenue-Increases-95-to-a-Record-7-8-Million.html

From 9-3-19, with mention of joint venture partners
https://www.outsourcing-pharma.com/Article/2019/09/03/Orgenesis-reports-record-revenue-as-it-looks-to-develop-scalable-processing-solutions-for-cell-therapies

From 10-5-19, Analyst puts price target at $9.00, Vanguard and Blackrock increase their positions
https://rivertonroll.com/news/2019/10/05/orgenesis-otcmktsorgs-coverage-initiated-at-benchmark.html